A quantitative systems pharmacology model for certolizumab pegol treatment in moderate-to-severe psoriasis

BACKGROUND: Psoriasis is a chronic immune-mediated inflammatory systemic disease with skin manifestations characterized by erythematous, scaly, itchy and/or painful plaques resulting from hyperproliferation of keratinocytes. Certolizumab pegol [CZP], a PEGylated antigen binding fragment of a humaniz...

Descripción completa

Detalles Bibliográficos
Autores principales: Coto-Segura, Pablo, Segú-Vergés, Cristina, Martorell, Antonio, Moreno-Ramírez, David, Jorba, Guillem, Junet, Valentin, Guerri, Filippo, Daura, Xavier, Oliva, Baldomero, Cara, Carlos, Suárez-Magdalena, Olaya, Abraham, Sonya, Mas, José Manuel
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10552644/
https://www.ncbi.nlm.nih.gov/pubmed/37809085
http://dx.doi.org/10.3389/fimmu.2023.1212981

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10552644/
https://www.ncbi.nlm.nih.gov/pubmed/37809085
http://dx.doi.org/10.3389/fimmu.2023.1212981

Ejemplares similares